Advertisement

Related Videos

Javid J. Moslehi, MD, on Cardiovascular and Thrombotic Considerations of Kinase Inhibitors: The Case of BTK Inhibitors

Mark Sculpher, PhD: How Do We Assess the Value of Cancer Drug Optimization?

Mark J. Ratain, MD: The Justification for a Randomized Trial of Low-Dose Ibrutinib

Daniel Goldstein, MD: Interventional Pharmacoeconomics - Why and How

Boon-Cher Goh, MD, on Cancer Drugs in Singapore: 3As (Availability, Accessibility, and Affordability)

Advertisement

Advertisement




May
07
Today In Oncology
Plasma miR-371a-3p Predicts Recurrence in Stage I Testicular Cancer: Interim Results From the CLIMATE Study
Promising Signal Only ctDNA in Early Breast Cancer Not Yet Ready for Clinical Use
AI Pathology Framework for Biological Understanding of Tumors
AI Model Enables Earlier Detection of Pancreatic Cancer on Routine CT Scans
Breast Density Reduction: Endoxifen vs Tamoxifen
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo